Search for 'Provider:Cancer chemotherapy and pharmacology,'

Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors.

By Castellano, Daniel. Cancer chemotherapy and pharmacology, 2015 . 75(6):1099-114. , Formato Vancouver: Castellano D, Grande E, Valle J, Capdevila J, Reidy Lagunes D, O'Connor JM et al. Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors. Cancer Chemother Pharmacol. 2015 Jun;75(6):1099-114.

Place Hold on Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors.

Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma.

By Castellano, Daniel. Cancer chemotherapy and pharmacology, 2014 . 73(6):1095-107. , Formato Vancouver: García Del Muro X, Gallardo E, García Carbonero I, Laínez N, José Méndez M, Maroto P et al. Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma. Cancer Chemother Pharmacol. 2014 Jun;73(6):1095-107.

Place Hold on Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma.

Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimen.

By Castellano, Daniel | Ghanem Cañete, Ismael. Cancer chemotherapy and pharmacology, 2014 . 73(4):857-67. , Formato Vancouver: Castellano DE, Bellmunt J, Maroto JP, Font Pous A, Morales Barrera R, Ghanem I et al. Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimen. Cancer Chemother Pharmacol. 2014 Apr;73(4):857-67.

Place Hold on Phase II clinical trial of PM00104 (Zalypsis(®)) in urothelial carcinoma patients progressing after first-line platinum-based regimen.

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.

By Coronado, C. | Cortés-Funes Castro, Hernán | López Martín, Ana | Paz-Ares Rodríguez, Luis. Cancer chemotherapy and pharmacology, 2013 . 72(1):75-83. , Formato Vancouver: Salazar R, Cortés-Funes H, Casado E, Pardo B, López-Martín A, Cuadra C et al. Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2013 Jul;72(1):75-83.

Place Hold on Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.